Nitrazepam is a benzodiazepine derivative classified as a hypnotic and anticonvulsant agent used primarily to treat insomnia and severe anxiety disorders. By enhancing the inhibitory effects of gamma-aminobutyric… Read more










Nitrazepam is a benzodiazepine derivative classified as a hypnotic and anticonvulsant agent used primarily to treat insomnia and severe anxiety disorders. By enhancing the inhibitory effects of gamma-aminobutyric acid in the central nervous system, this drug effectively induces sedation. To support stringent regulatory requirements and analytical accuracy, this category provides high-quality reference standards for the Nitrazepam active pharmaceutical ingredient. Laboratories rely on these materials, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds, to conduct precise impurity profiling and method validation. Using these reference materials ensures consistency in quality control protocols, enabling accurate quantification and identification of drug-related substances in complex biological or pharmaceutical matrices.